Skip to main content
Contact +1 (919) 234-1277

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1-G2-kappa

$238.00

100ug + 238 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb

Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade

Product name Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade
Source CAS 1422527-84-1
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Tafasitamab,MOR-00208,MOR-208,XENP-5574,XMP-5574,XmAb-5574,Xmab-CD19,CD19,anti-CD19
Reference PX-TA1365
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-G2-kappa
Clonality Monoclonal Antibody
Product name Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade
Source CAS 1422527-84-1
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Tafasitamab,MOR-00208,MOR-208,XENP-5574,XMP-5574,XmAb-5574,Xmab-CD19,CD19,anti-CD19
Reference PX-TA1365
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-G2-kappa
Clonality Monoclonal Antibody

General information on Anti-CD19[Homo sapiens] (Tafasitamab) Monoclonal Antibody

Tafasitamab is a humanized monoclonal antibody that targets CD19. It is used for the treatment of B-cell malignancies. The CD19 surface protein is highly expressed on the surface of B-cells where it enhances B-cell receptor signaling. CD19 is especially expressed in cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL). By its activity, tafasatimab induces the lysis of B-cells.

SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb

SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb

Tafasitamab Biosimilar - Anti-CD19 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products